<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">helmholtzeyeinstitute</journal-id><journal-title-group><journal-title xml:lang="ru">Российский офтальмологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Ophthalmological Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0076</issn><issn pub-type="epub">2587-5760</issn><publisher><publisher-name>Real time Publishers</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21516/2072-0076-2023-16-1-145-150</article-id><article-id custom-type="elpub" pub-id-type="custom">helmholtzeyeinstitute-1185</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>Возможности и перспективы применения оптической когерентной томографии и оптической когерентной томографии с функцией ангиографии в диагностике эндокринной офтальмопатии</article-title><trans-title-group xml:lang="en"><trans-title>Optical coherence tomography and optical coherence tomography — angiography used in endocrine ophthalmopathy</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гаврилова</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gavrilova</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Наталья Александровна Гаврилова — д-р мед. наук, профессор, заведующая кафедрой глазных болезней</p><p>ул. Делегатская, д. 20/1, Москва, 127473</p></bio><bio xml:lang="en"><p>Natalia A. Gavrilova — Dr. of Med. Sci., professor, head of chair of eye diseases</p><p>20/1, Delegatskaya St., Moscow, 127473</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кутровская</surname><given-names>Н. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Kutrovskaya</surname><given-names>N. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Наталья Юрьевна Кутровская — канд. мед. наук, доцент кафедры глазных болезней</p><p>ул. Делегатская, д. 20/1, Москва, 127473</p></bio><bio xml:lang="en"><p> Natalia Yu. Kutrovskaya — Cand. of Med. Sci., assistant professor, chair of eye diseases</p><p>20/1, Delegatskaya St., Moscow, 127473</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5410-2000</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Салимова</surname><given-names>Х. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Salimova</surname><given-names>Kh. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ханум Назимовна Салимова — аспирант кафедры глазных болезней </p><p>ул. Делегатская, д. 20/1, Москва, 127473</p></bio><bio xml:lang="en"><p>Khanum N. Salimova — PhD student, chair of eye diseases </p><p>20/1, Delegatskaya St., Moscow, 127473</p></bio><email xlink:type="simple">salimova.xanumka@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>A.I. Yevdokimov State Medical and Stomatological University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>18</day><month>03</month><year>2023</year></pub-date><volume>16</volume><issue>1</issue><fpage>145</fpage><lpage>150</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Гаврилова Н.А., Кутровская Н.Ю., Салимова Х.Н., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Гаврилова Н.А., Кутровская Н.Ю., Салимова Х.Н.</copyright-holder><copyright-holder xml:lang="en">Gavrilova N.A., Kutrovskaya N.Y., Salimova K.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://roj.igb.ru/jour/article/view/1185">https://roj.igb.ru/jour/article/view/1185</self-uri><abstract><p>Представлены результаты применения оптической когерентной томографии и оптической когерентной томографии — ангиографии при эндокринной офтальмопатии (ЭОП). Проанализированы данные исследований толщины внутренних слоев сетчатки, микроциркуляции в перипапиллярной и макулярной областях, параметров хориоидеи, решетчатой пластинки склеры и экстраокулярных мышц как возможных диагностических критериев ЭОП.</p></abstract><trans-abstract xml:lang="en"><p>The literature review presents the results of optical coherence tomography and optical coherence tomography — angiography used for Graves’ orbitopathy. The data on the thickness of the inner layers of the retina, microcirculation in the peripapillary and macular regions, parameters of the choroid, lamina cribrosa and extraocular muscles were analyzed as possible diagnostic criteria of the condition.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>эндокринная офтальмопатия</kwd><kwd>оптическая нейропатия</kwd><kwd>оптическая когерентная томография</kwd><kwd>оптическая когерентная томография с расширенной глубинной визуализацией</kwd><kwd>оптическая когерентная томография — ангиография</kwd><kwd>слой нервных волокон сетчатки</kwd></kwd-group><kwd-group xml:lang="en"><kwd>endocrine ophthalmopathy</kwd><kwd>optic neuropathy</kwd><kwd>optical coherence tomography</kwd><kwd>enhanced depth imaging optical coherence tomography</kwd><kwd>optical coherence tomography — angiography</kwd><kwd>retinal nerve fiber layer</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">McKeag D., Lane C., Lazarus J.H., et al. Clinical features of dysthyroid optic neuropathy: a European group on Graves' orbitopathy (EUGOGO) survey. Br. J. Ophthalmol. 2007; 91 (4): 455–8. doi: 10.1136/bjo.2006.094607</mixed-citation><mixed-citation xml:lang="en">McKeag D., Lane C., Lazarus J.H., et al. Clinical features of dysthyroid optic neuropathy: a European group on Graves' orbitopathy (EUGOGO) survey. Br. J. Ophthalmol. 2007; 91 (4): 455–8. doi: 10.1136/bjo.2006.094607</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Acaroglu G., Simsek T., Ozalp S., Mutluay A. Subclinical optic neuropathy in Graves' orbitopathy. Jap. J. Ophthalmol. 2003; 47 (5): 459–62. doi: 10.1016/ s0021-5155(03)00101-1</mixed-citation><mixed-citation xml:lang="en">Acaroglu G., Simsek T., Ozalp S., Mutluay A. Subclinical optic neuropathy in Graves' orbitopathy. Jap. J. Ophthalmol. 2003; 47 (5): 459–62. doi: 10.1016/ s0021-5155(03)00101-1</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bartalena L., Pinchera A., Marcocci C. Management of Graves’ ophthalmopathy: reality and perspectives. Endocr. Rev. 2000; 21 (2): 168–99. doi: 10.1210/ edrv.21.2.0393</mixed-citation><mixed-citation xml:lang="en">Bartalena L., Pinchera A., Marcocci C. Management of Graves’ ophthalmopathy: reality and perspectives. Endocr. Rev. 2000; 21 (2): 168–99. doi: 10.1210/ edrv.21.2.0393</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Харинцева С.В., Серебрякова О.В., Харинцев В.В., Cеркин Д.М. Оптическая когерентная томография в диагностике нейропатии у больных с эндокринной офтальмопатией. Бюллетень ВСНЦ СО РАМН. 2011; 6: 97–9.</mixed-citation><mixed-citation xml:lang="en">Kharintseva S.V., Serebryakova O.V., Kharintsev V.V., Serkin D.M. Optic coherent tomography in optic neuropathy diagnostics in patients with endocrine ophthalmopathy. Bull. Vost. Sib. Naucn. Sent. 2011; 6: 97–9 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Park K.A., Kim Y.D., In Woo K., Kee C., Han J.C. Optical coherence tomography measurements in compressive optic neuropathy associated with dysthyroid orbitopathy. Graefes Arch. Clin. Exp. Ophthalmol. 2016; 254 (8): 1617–24. doi: 10.1007/s00417-016-3335-9</mixed-citation><mixed-citation xml:lang="en">Park K.A., Kim Y.D., In Woo K., Kee C., Han J.C. Optical coherence tomography measurements in compressive optic neuropathy associated with dysthyroid orbitopathy. Graefes Arch. Clin. Exp. Ophthalmol. 2016; 254 (8): 1617–24. doi: 10.1007/s00417-016-3335-9</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Саакян С.В., Пантелеева О.Г., Мякошина Е.Б., Сирмайс О.С. Способ определения стадии оптической нейропатии при эндокринной офтальмопатии с помощью спектральной оптической когерентной томографии. Патент РФ № 2535403 C1; 2013.</mixed-citation><mixed-citation xml:lang="en">Saakjan S.V., Panteleeva O.G., Mjakoshina E.B, Sirmajs O.S. Method for staging optic neuropathy accompanying endocrine ophthalmopathy by spectral optical coherence tomography Pat. RF 2535403 C1; 2013 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Meirovitch S.B., Leibovitch I., Kesler A., et al. Retina and nerve fiber layer thickness in eyes with thyroid-associated ophthalmopathy. Isr. Med. Assoc. J. 2017; 19 (5): 277–81.</mixed-citation><mixed-citation xml:lang="en">Meirovitch S.B., Leibovitch I., Kesler A., et al. Retina and nerve fiber layer thickness in eyes with thyroid-associated ophthalmopathy. Isr. Med. Assoc. J. 2017; 19 (5): 277–81.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Romano M.R., Cennamo G., Breve M.A., et al. Optic nerve compression: the role of the lamina cribrosa and translaminar pressure. Int. J. Ophthalmol. 2017; 10 (12): 1883–8. doi: 10.18240/ijo.2017.12.15</mixed-citation><mixed-citation xml:lang="en">Romano M.R., Cennamo G., Breve M.A., et al. Optic nerve compression: the role of the lamina cribrosa and translaminar pressure. Int. J. Ophthalmol. 2017; 10 (12): 1883–8. doi: 10.18240/ijo.2017.12.15</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Wu Y., Tu Y., Wu C., et al. Reduced macular inner retinal thickness and microvascular density in the early stage of patients with dysthyroid optic neuropathy. Eye Vis. (Lond). 2020; 7: 16. doi: 10.1186/s40662-020-00180-9</mixed-citation><mixed-citation xml:lang="en">Wu Y., Tu Y., Wu C., et al. Reduced macular inner retinal thickness and microvascular density in the early stage of patients with dysthyroid optic neuropathy. Eye Vis. (Lond). 2020; 7: 16. doi: 10.1186/s40662-020-00180-9</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang T., Xiao W., Ye H., et al. Peripapillary and macular vessel density in dysthyroid optic neuropathy: an optical coherence tomography angiography study. Invest. Ophthalmol. Vis. Sci. 2019; 60 (6): 1863–9. doi: 10.1167/iovs.18- 25941</mixed-citation><mixed-citation xml:lang="en">Zhang T., Xiao W., Ye H., et al. Peripapillary and macular vessel density in dysthyroid optic neuropathy: an optical coherence tomography angiography study. Invest. Ophthalmol. Vis. Sci. 2019; 60 (6): 1863–9. doi: 10.1167/iovs.18- 25941</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Yu L., Jiao Q., Cheng Y., et al. Evaluation of retinal and choroidal variations in thyroid-associated ophthalmopathy using optical coherence tomography angiography. BMC Ophthalmology. 2020; 20 (1): 421. doi: 10.1186/s12886- 020-01692-7</mixed-citation><mixed-citation xml:lang="en">Yu L., Jiao Q., Cheng Y., et al. Evaluation of retinal and choroidal variations in thyroid-associated ophthalmopathy using optical coherence tomography angiography. BMC Ophthalmology. 2020; 20 (1): 421. doi: 10.1186/s12886- 020-01692-7</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Tehrani M.J., Mahdizad Z., Kasaei A., Fard M.A. Early macular and peripapillary vasculature dropout in active thyroid eye disease. Graefe's archive for clinical and experimental ophthalmology. 2019; 257 (11): 2533–40. doi: 10.1007/ s00417-019-04442-8</mixed-citation><mixed-citation xml:lang="en">Tehrani M.J., Mahdizad Z., Kasaei A., Fard M.A. Early macular and peripapillary vasculature dropout in active thyroid eye disease. Graefe's archive for clinical and experimental ophthalmology. 2019; 257 (11): 2533–40. doi: 10.1007/ s00417-019-04442-8</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Rajabi M.T., Ojani M., Esfahani H.R., et al. Correlation of peripapillary nerve fiber layer thickness with visual outcomes after decompression surgery in subclinical and clinical thyroid-related compressive optic neuropathy. J. Curr. Ophthalmol. 2018; 31 (1): 86–91. doi: 10.1016/j.joco.2018.11</mixed-citation><mixed-citation xml:lang="en">Rajabi M.T., Ojani M., Esfahani H.R., et al. Correlation of peripapillary nerve fiber layer thickness with visual outcomes after decompression surgery in subclinical and clinical thyroid-related compressive optic neuropathy. J. Curr. Ophthalmol. 2018; 31 (1): 86–91. doi: 10.1016/j.joco.2018.11</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Vupparaboina K.K., Dansingani K.K., Goud A., et al. Quantitative shadow compensated optical coherence tomography of choroidal vasculature. Sci Rep. 2018; 8 (1): 6461. doi: 10.1038/s41598-018-24577-8</mixed-citation><mixed-citation xml:lang="en">Vupparaboina K.K., Dansingani K.K., Goud A., et al. Quantitative shadow compensated optical coherence tomography of choroidal vasculature. Sci Rep. 2018; 8 (1): 6461. doi: 10.1038/s41598-018-24577-8</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Семенова Н.С., Ларичев А.В., Акопян В.С. Swept source — оптическая когерентная томография: обзор технологии. Вестник офтальмологии. 2020; 136 (1): 111–6. doi: 10.17116/oftalma2020136011111</mixed-citation><mixed-citation xml:lang="en">Semenova N.S., Larichev A.V., Akopyan V.S. Swept source optical coherence tomography: a technology review. Vestnik oftalmologii. 2020; 136 (1): 111–6 (in Russian). doi: 10.17116/oftalma2020136011111</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Agrawal R., Gupta P., Tan K.A., et al. Choroidal vascularity index as a measure of vascular status of the choroid: measurements in healthy eyes from a populationbased study. Sci Rep. 2016; 6: 21090. doi: 10.1038/srep21090</mixed-citation><mixed-citation xml:lang="en">Agrawal R., Gupta P., Tan K.A., et al. Choroidal vascularity index as a measure of vascular status of the choroid: measurements in healthy eyes from a populationbased study. Sci Rep. 2016; 6: 21090. doi: 10.1038/srep21090</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Bruscolini A., Cava M.L., Gharbiya M., et al. Management of patients with Graves’ disease and orbital involvement: role of spectral domain optical coherence tomography. J. Immunol. Res. 2018; 2018: 1454616. doi: 10.1155/2018/1454616</mixed-citation><mixed-citation xml:lang="en">Bruscolini A., Cava M.L., Gharbiya M., et al. Management of patients with Graves’ disease and orbital involvement: role of spectral domain optical coherence tomography. J. Immunol. Res. 2018; 2018: 1454616. doi: 10.1155/2018/1454616</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Cagiltay E., Akay F., Demir O., et al. The increment of choroidal thickness in euthyroid Graves’ ophthalmopathy: Is it an early sign of venous congestion? J. Ophthalmol. 2018; 2018: 5891531. doi: 10.1155/2018/5891531</mixed-citation><mixed-citation xml:lang="en">Cagiltay E., Akay F., Demir O., et al. The increment of choroidal thickness in euthyroid Graves’ ophthalmopathy: Is it an early sign of venous congestion? J. Ophthalmol. 2018; 2018: 5891531. doi: 10.1155/2018/5891531</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Caliskan S., Acar M., Gurdal C. Choroidal thickness in patients with Graves’ ophthalmopathy. Curr. Eye Res. 2017; 42 (3): 484–90. doi: 10.1080/02713683.2016.1198488</mixed-citation><mixed-citation xml:lang="en">Caliskan S., Acar M., Gurdal C. Choroidal thickness in patients with Graves’ ophthalmopathy. Curr. Eye Res. 2017; 42 (3): 484–90. doi: 10.1080/02713683.2016.1198488</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Lai F.H.P., Iao T.W.U., Ng D.S.C., et al. Choroidal thickness in thyroidassociated orbitopathy. Clin. Exp. Ophthalmol. 2019; 47 (7): 918–24. doi: 10.1111/ceo.13525</mixed-citation><mixed-citation xml:lang="en">Lai F.H.P., Iao T.W.U., Ng D.S.C., et al. Choroidal thickness in thyroidassociated orbitopathy. Clin. Exp. Ophthalmol. 2019; 47 (7): 918–24. doi: 10.1111/ceo.13525</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Laplant J., Azar S., Caplan C., De La Rosa S., Hubbell M. Applications of optical coherence tomography in thyroid eye disease. Invest. Ophthalmol. Vis. Sci. 2019; 60 (9): 1889. https://iovs.arvojournals.org/article.aspx?articleid=2746659</mixed-citation><mixed-citation xml:lang="en">Laplant J., Azar S., Caplan C., De La Rosa S., Hubbell M. Applications of optical coherence tomography in thyroid eye disease. Invest. Ophthalmol. Vis. Sci. 2019; 60 (9): 1889. https://iovs.arvojournals.org/article.aspx?articleid=2746659</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Ozkan B., Kozer C. A., Altintas O., et al. Choroidal changes observed with enhanced de0pth imaging optical coherence tomography in patients with mild Graves orbitopathy. Eye (Lond). 2016; 30 (7): 917–24. doi: 10.1038/eye.2016.93</mixed-citation><mixed-citation xml:lang="en">Ozkan B., Kozer C. A., Altintas O., et al. Choroidal changes observed with enhanced de0pth imaging optical coherence tomography in patients with mild Graves orbitopathy. Eye (Lond). 2016; 30 (7): 917–24. doi: 10.1038/eye.2016.93</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Yu N., Zhang Y., Kang L., et al. Analysis in choroidal thickness in patients with Graves’ ophthalmopathy using spectral-domain optical coherence tomography. J. Ophthalmol. 2018; 2018: 3529395. doi: 10.1155/2018/3529395</mixed-citation><mixed-citation xml:lang="en">Yu N., Zhang Y., Kang L., et al. Analysis in choroidal thickness in patients with Graves’ ophthalmopathy using spectral-domain optical coherence tomography. J. Ophthalmol. 2018; 2018: 3529395. doi: 10.1155/2018/3529395</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Kurt M.M., Akpolat C., Evliyaoglu F., Yilmaz M., Ordulu F. Evaluation of retinal neurodegeneration and choroidal thickness in patients with inactive Graves' ophthalmopathy. Klinische Monatsbl tter f r Augenheilkunde. 2021; 238 (7): 797–802. doi: 10.1055/a-1275-0703</mixed-citation><mixed-citation xml:lang="en">Kurt M.M., Akpolat C., Evliyaoglu F., Yilmaz M., Ordulu F. Evaluation of retinal neurodegeneration and choroidal thickness in patients with inactive Graves' ophthalmopathy. Klinische Monatsbl tter f r Augenheilkunde. 2021; 238 (7): 797–802. doi: 10.1055/a-1275-0703</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Loiudice P., Pellegrini M., Marin M., et al. Choroidal vascularity index in thyroid-associated ophthalmopathy: a cross-sectional study. Eye Vis. (Lond). 2021; 8 (1): 18. doi: 10.1186/s40662-021-00242-6</mixed-citation><mixed-citation xml:lang="en">Loiudice P., Pellegrini M., Marin M., et al. Choroidal vascularity index in thyroid-associated ophthalmopathy: a cross-sectional study. Eye Vis. (Lond). 2021; 8 (1): 18. doi: 10.1186/s40662-021-00242-6</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Yeter V., Ko ak N., Suba M., Parlak U. Choroidal vascularity index in thyroid-associated ophthalmopathy. Can. J. Ophthalmol. 2021; S 0008- 4182(21)00249-0. doi: 10.1016/j.jcjo.2021.06.023</mixed-citation><mixed-citation xml:lang="en">Yeter V., Ko ak N., Suba M., Parlak U. Choroidal vascularity index in thyroid-associated ophthalmopathy. Can. J. Ophthalmol. 2021; S 0008- 4182(21)00249-0. doi: 10.1016/j.jcjo.2021.06.023</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Aksoy M., Simsek M., Apayd n M. Evaluation of choroidal circulation and stromal features in Graves’ disease. Eur J. Ophthalmol. 2022; 32 (3): 1680–6. doi: 10.1177/11206721211031406</mixed-citation><mixed-citation xml:lang="en">Aksoy M., Simsek M., Apayd n M. Evaluation of choroidal circulation and stromal features in Graves’ disease. Eur J. Ophthalmol. 2022; 32 (3): 1680–6. doi: 10.1177/11206721211031406</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Girard M.J.A., Tun T.A., Husain R., et al. Lamina cribrosa visibility using optical coherence tomography: comparison of devices and effects of image enhancement techniques. Invest. Ophthalmol. Vis. Sci. 2015; 56 (2): 865–74. doi: 10.1167/iovs.14-14903</mixed-citation><mixed-citation xml:lang="en">Girard M.J.A., Tun T.A., Husain R., et al. Lamina cribrosa visibility using optical coherence tomography: comparison of devices and effects of image enhancement techniques. Invest. Ophthalmol. Vis. Sci. 2015; 56 (2): 865–74. doi: 10.1167/iovs.14-14903</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Paulo A., Vaz P.G., Jesus D.A.D., et al. Optical coherence tomography imaging of the lamina cribrosa: structural biomarkers in nonglaucomatous diseases. J. Ophthalmol. 2021; 2021: 8844614:31. doi: 10.1155/2021/8844614</mixed-citation><mixed-citation xml:lang="en">Paulo A., Vaz P.G., Jesus D.A.D., et al. Optical coherence tomography imaging of the lamina cribrosa: structural biomarkers in nonglaucomatous diseases. J. Ophthalmol. 2021; 2021: 8844614:31. doi: 10.1155/2021/8844614</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Lee S.H., Yu. D.A., Kim T.W., et al. Reduction of the lamina cribrosa curvature after trabeculectomy in glaucoma. Investigative ophthalmology visual science. 2016; 57 (11): 5006–14. doi: 10.1167/iovs.15-18982</mixed-citation><mixed-citation xml:lang="en">Lee S.H., Yu. D.A., Kim T.W., et al. Reduction of the lamina cribrosa curvature after trabeculectomy in glaucoma. Investigative ophthalmology visual science. 2016; 57 (11): 5006–14. doi: 10.1167/iovs.15-18982</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Lee S.H., Kim T.W., Lee E.J., Girard M.J.A., Mari J.M. Focal lamina cribrosa defects are not associated with steep lamina cribrosa curvature but with choroidal microvascular dropout. Scie Rep. 2020; 10 (1): 6761. doi: 10.1038/s41598-020- 63681-6</mixed-citation><mixed-citation xml:lang="en">Lee S.H., Kim T.W., Lee E.J., Girard M.J.A., Mari J.M. Focal lamina cribrosa defects are not associated with steep lamina cribrosa curvature but with choroidal microvascular dropout. Scie Rep. 2020; 10 (1): 6761. doi: 10.1038/s41598-020- 63681-6</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Luo H., Yang H., Gardiner S.K., et al. Factors influencing central lamina cribrosa depth: a multicenter study. Invest. Ophthalmol. Vis. Sci. 2018; 59 (6): 2357–70. doi: 10.1167/iovs.17-23456</mixed-citation><mixed-citation xml:lang="en">Luo H., Yang H., Gardiner S.K., et al. Factors influencing central lamina cribrosa depth: a multicenter study. Invest. Ophthalmol. Vis. Sci. 2018; 59 (6): 2357–70. doi: 10.1167/iovs.17-23456</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Иомдина Е.Н., Киселёва О.А., Хозиев Д.Д. и др. Способ ранней диагностики первичной открытоугольной глаукомы. Патент РФ № 2698931; 2019.</mixed-citation><mixed-citation xml:lang="en">Iomdina E.N., Kiseleva O.A., Khoziev D.D., et al. Method for early diagnosis of primary open-angle glaucoma. Patent RF 2698931; 2019 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Rebolleda G., P rez-Sarriegui A., D ez- lvarez L., et al. Lamina cribrosa position and bruch’s membrane opening differences between anterior ischemic optic neuropathy and open-angle glaucoma. Eur. J. Ophthalmol. 2019; 29 (2): 202–9. doi: 10.1177/1120672118782101</mixed-citation><mixed-citation xml:lang="en">Rebolleda G., P rez-Sarriegui A., D ez- lvarez L., et al. Lamina cribrosa position and bruch’s membrane opening differences between anterior ischemic optic neuropathy and open-angle glaucoma. Eur. J. Ophthalmol. 2019; 29 (2): 202–9. doi: 10.1177/1120672118782101</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Akkaya S., K k B., Do an H.K., Can E. Evaluation of the lamina cribrosa in patients with diabetes mellitus using enhanced depth imaging spectral-domain optical coherence tomography. Diab. Vasc. Dis Res. 2018; 15 (5): 442–8. doi: 10.1177/1479164118782091</mixed-citation><mixed-citation xml:lang="en">Akkaya S., K k B., Do an H.K., Can E. Evaluation of the lamina cribrosa in patients with diabetes mellitus using enhanced depth imaging spectral-domain optical coherence tomography. Diab. Vasc. Dis Res. 2018; 15 (5): 442–8. doi: 10.1177/1479164118782091</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Eraslan M., Eren C., Balci S.Y., et al. The choroid and lamina cribrosa is affected in patients with Parkinson’s disease: enhanced depth imaging optical coherence tomography study. Acta Ophthalmologica. 2016; 94 (1): 68–75. doi: 10.1111/ aos.12809</mixed-citation><mixed-citation xml:lang="en">Eraslan M., Eren C., Balci S.Y., et al. The choroid and lamina cribrosa is affected in patients with Parkinson’s disease: enhanced depth imaging optical coherence tomography study. Acta Ophthalmologica. 2016; 94 (1): 68–75. doi: 10.1111/ aos.12809</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Kucuk B., Strakaya E., Deliba S. Posterior segment assessment in patients with obstructive sleep apnea syndrome. Sleep Breath. 2019; 23 (3): 997–1005. doi: 10.1007/s11325-019-01837-z</mixed-citation><mixed-citation xml:lang="en">Kucuk B., Strakaya E., Deliba S. Posterior segment assessment in patients with obstructive sleep apnea syndrome. Sleep Breath. 2019; 23 (3): 997–1005. doi: 10.1007/s11325-019-01837-z</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Lopez-de Eguileta A., Lage C., Lopez-Garcia S., et al. Ganglion cell layer thinning in prodromal Alzheimer’s disease defined by amyloid pet. Alzheimers Dement (N. Y.). 2019; 5: 570–8. doi: 10.1016/j.trci.2019.08.008</mixed-citation><mixed-citation xml:lang="en">Lopez-de Eguileta A., Lage C., Lopez-Garcia S., et al. Ganglion cell layer thinning in prodromal Alzheimer’s disease defined by amyloid pet. Alzheimers Dement (N. Y.). 2019; 5: 570–8. doi: 10.1016/j.trci.2019.08.008</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Lee E.J., Kim T.-W., Lee D.S., et al. Increased CSF tau level is correlated with decreased lamina cribrosa thickness. Alzheimers Res. Ther. 2016; 8: 6. doi: 10.1186/s13195-015-0169-3</mixed-citation><mixed-citation xml:lang="en">Lee E.J., Kim T.-W., Lee D.S., et al. Increased CSF tau level is correlated with decreased lamina cribrosa thickness. Alzheimers Res. Ther. 2016; 8: 6. doi: 10.1186/s13195-015-0169-3</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Seo Y., Shin W.B., Bae H.W., Yoon J.S. Effects of orbital decompression on lamina cribrosa depth in patients with Graves' orbitopathy. Korean J. Ophthalmol. 2019; 33 (5): 436–45. doi: 10.3341/ kjo.2019.0036</mixed-citation><mixed-citation xml:lang="en">Seo Y., Shin W.B., Bae H.W., Yoon J.S. Effects of orbital decompression on lamina cribrosa depth in patients with Graves' orbitopathy. Korean J. Ophthalmol. 2019; 33 (5): 436–45. doi: 10.3341/ kjo.2019.0036</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Нaner N.U., Dysli M., Abegg M., Zinkernagel M.S. Enhanced-depth optical coherence tomography for imaging horizontal rectus muscles in Graves’ orbitopathy. Graefes Arch. Clin. Exp. Ophthalmol. 2015; 253 (9): 1569–73. doi: 10.1007/s00417-015-3060-9</mixed-citation><mixed-citation xml:lang="en">Нaner N.U., Dysli M., Abegg M., Zinkernagel M.S. Enhanced-depth optical coherence tomography for imaging horizontal rectus muscles in Graves’ orbitopathy. Graefes Arch. Clin. Exp. Ophthalmol. 2015; 253 (9): 1569–73. doi: 10.1007/s00417-015-3060-9</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">De-Pablo-Gomez-de-Liano L., Fernandez-Vigo J.I., Ventura-Abreu N., et al. OСT thickness measurements of the extraocular rectus muscle tendons in Graves' ophthalmopathy. Pediatric Ophthalmol. Strabismus. 2018; 55 (6): 356–62. doi: 10.3928/01913913-20180802-01</mixed-citation><mixed-citation xml:lang="en">De-Pablo-Gomez-de-Liano L., Fernandez-Vigo J.I., Ventura-Abreu N., et al. OСT thickness measurements of the extraocular rectus muscle tendons in Graves' ophthalmopathy. Pediatric Ophthalmol. Strabismus. 2018; 55 (6): 356–62. doi: 10.3928/01913913-20180802-01</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
